SCHEMBL3760714

SCHEMBL3760714

O=C1NN(c2ccc(Cl)c(Cl)c2)C(=O)/C1=C/c1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 8/20 1.00
ABL1 P00519 3/20 0.58
SRC P12931 3/20 0.58
MEN1 O00255 7/20 0.57
KMT2A Q03164 7/20 0.57
GAA P10253 3/20 0.57
POLB P06746 4/20 0.54
GALK1 P51570 1/20 0.54
GFER P55789 1/20 0.54
HKDC1 Q2TB90 1/20 0.54
EGFR P00533 1/20 0.53
NR4A1 P22736 1/20 0.53
ALDH1A1 P00352 1/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
ALOX12 P18054 1/20 0.53
RECQL P46063 1/20 0.53
MCL1 Q07820 1/20 0.53
PSMD14 O00487 1/20 0.52
MMP2 P08253 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3760715 1.00 DYRK1A (1.00) DYRK1AABL1SRCMEN1KMT2A
SCHEMBL3760719 1.00 DYRK1A (1.00) DYRK1AABL1SRCMEN1KMT2A
SCHEMBL2184453 0.82 DYRK1A (0.84) DYRK1AABL1SRCMEN1KMT2A
SCHEMBL18841380 0.82 DYRK1A (0.75) DYRK1AABL1SRCMEN1KMT2A
SCHEMBL2184451 0.82 DYRK1A (0.84) DYRK1AABL1SRCMEN1KMT2A
SCHEMBL18420223 0.79 DYRK1A (1.00) DYRK1AMEN1KMT2AGAAPOLB
SCHEMBL18844753 0.79 DYRK1A (1.00) DYRK1AMEN1KMT2AGAAPOLB
SCHEMBL18420224 0.79 DYRK1A (1.00) DYRK1AMEN1KMT2AGAAPOLB
SCHEMBL22275107 0.77 DYRK1A (0.62) DYRK1AABL1SRCMEN1KMT2A
SCHEMBL13056452 0.74 DYRK1A (0.63) DYRK1AABL1SRCMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE FADS2, ACOT7, FADS1 DYRK1A 4302/4885ABL1 3996/4885SRC 4284/4885
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE FADS2, ACOT7, FADS1 DYRK1A 4302/4885ABL1 3996/4885SRC 4284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.